Shanghai Cell Therapy Group Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 70

Employees
  • Latest Deal Type

  • Later Stage VC

  • Investors

  • 13

Shanghai Cell Therapy Group General Information

Description

Developer of tumour immune cell therapy treatments. The company operates a cellular diagnosis center and provides immune cell research and treatment services. The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities.

Contact Information

Website
www.shcell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Building A, No. 75 Qianyang Road
  • Jiading District
  • Shanghai, 201805
  • China
+86 400 000 0000

Shanghai Cell Therapy Group Timeline

2020202120222023
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Cell Therapy Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 08-Feb-2022 00000 Completed Generating Revenue
7. Later Stage VC (Series D1) 28-May-2021 000.00 00000 00.000 Completed Generating Revenue
6. Later Stage VC (Series C2) 01-Dec-2018 000.00 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series C1) 01-Oct-2018 000.00 000.00 00000 Completed Generating Revenue
4. Early Stage VC 26-Jun-2018 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 18-Apr-2016 000.00 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Jun-2014 $20.8M $20.8M 000.00 Completed Generating Revenue
1. Joint Venture 29-Nov-2013 Completed Generating Revenue
To view Shanghai Cell Therapy Group’s complete valuation and funding history, request access »

Shanghai Cell Therapy Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tumour immune cell therapy treatments. The company operates a cellular diagnosis center and provides immune
Biotechnology
Shanghai, China
70 As of 2015
00000
0000000000 0 00000

000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
Beijing, China
000 As of 0000
00000
0000000 0000 00000

000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shanghai Cell Therapy Group Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mabworks Biotech Private Equity-Backed Beijing, China 000 00000 0000000 0000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000000000000 Venture Capital-Backed Saint Louis, MO 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000000000 Formerly VC-backed Beijing, China 0000 00000 00000000 00000
You’re viewing 5 of 38 competitors. Get the full list »

Shanghai Cell Therapy Group Patents

  • 19

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 7

    Pending

  • 000

    Expiring in next 12 mo

Shanghai Cell Therapy Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4081545-A2 Cell expressing immune modulatory molecules and system for expressing immune modulatory molecules Pending 28-Dec-2019 0000000000
CA-3161286-A1 Promoter having high activity in activated t-cell Pending 15-Nov-2019 0000000000
EP-4060042-A1 Promoter having high activity in activated t-cell Pending 15-Nov-2019 0000000000 0
JP-2023502098-A Promoter with high activity in activated t cells Pending 15-Nov-2019
US-20220372481-A1 Promoter having high activity in activated t-cell Pending 15-Nov-2019 C12N15/85
To view Shanghai Cell Therapy Group’s complete patent history, request access »

Shanghai Cell Therapy Group Executive Team (2)

Name Title Board Seat Contact Info
Na Ding Ph.D Chief Operating Officer
Qijun Qian MD Chairman & Executive Director
To view Shanghai Cell Therapy Group’s complete executive team members history, request access »

Shanghai Cell Therapy Group Board Members (1)

Name Representing Role Since
Qijun Qian MD Shanghai Cell Therapy Group Chairman & Executive Director 000 0000
To view Shanghai Cell Therapy Group’s complete board members history, request access »

Shanghai Cell Therapy Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shanghai Cell Therapy Group Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Xiyang Investment Venture Capital Minority 000 0000 000000 0
CCB International PE/Buyout Minority 000 0000 000000 0
Jiuzhou Venture Venture Capital Minority 000 0000 000000 0
Sun Rock Capital Venture Capital Minority 000 0000 000000 0
China Pacific Life Insurance Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial